Clinical, angiographic, functional, and imaging outcomes 12 months after implantation of drug-eluting bioresorbable vascular scaffolds in acute coronary syndromes

JACC: Cardiovascular Interventions

Volumn 8, Issue 6, 2015, Pages 770-777

  Gori, Tommaso ^a   Schulz, Eberhard ^a   Hink, Ulrich ^a   Kress, Madeleine ^a   Weiers, Nadja ^a   Weissner, Melissa ^a   Jabs, Alexander ^a   Wenzel, Philip ^a   Capodanno, Davide ^b   Münzel, Thomas ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

acute myocardial infarction; bioresorbable scaffolds; endothelial function; optical coherence tomography

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BINARY RESTENOSIS; BIORESORBABLE VASCULAR STENT; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RESPONSE; CLINICAL EVALUATION; CLINICAL FEATURE; CORONARY ARTERY DILATATION; CORONARY STENTING; EVEROLIMUS ELUTING CORONARY STENT; FEMALE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT MALAPPOSITION; STENT THROMBOSIS; SUDDEN DEATH; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS; ADVERSE EFFECTS; AGED; BIODEGRADABLE IMPLANT; CONVALESCENCE; CORONARY ANGIOGRAPHY; CORONARY BLOOD VESSEL; CORONARY RESTENOSIS; CORONARY THROMBOSIS; DEVICES; MIDDLE AGED; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PROSTHESIS DESIGN; RADIOGRAPHY; REGISTER; TIME FACTOR; VASODILATATION;

BIOCOMPATIBLE COATED MATERIAL; CARDIOVASCULAR AGENT;

ABSORBABLE IMPLANTS; ACUTE CORONARY SYNDROME; AGED; CARDIOVASCULAR AGENTS; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY THROMBOSIS; CORONARY VESSELS; FEMALE; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; RECOVERY OF FUNCTION; REGISTRIES; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASODILATION;

EID: 84929573228     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2014.12.244     Document Type: Article

References (24)

1. J. Iqbal, Y. Onuma, J. Ormiston, A. Abizaid, R. Waksman, and P. Serruys Bioresorbable scaffolds: rationale, current status, challenges, and future Eur Heart J 35 2014 765 776
2. S. Brugaletta, J.H. Heo, and H.M. Garcia-Garcia Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy? Eur Heart J 33 2012 1325 1333
3. R. Diletti, V. Farooq, and C. Girasis Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial Heart 99 2013 98 105
4. V. Kocka, M. Maly, and P. Tousek Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study 'Prague 19.' Eur Heart J 35 2014 787 794
5. R. Diletti, A. Karanasos, and T. Muramatsu Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study Eur Heart J 35 2014 777 786
6. W. Zasada, L. Rzeszutko, A. Dziewierz, and D. Dudek Patient with non-ST-segment elevation myocardial infarction treated by Absorb bioresorbable scaffold implantation Kardiol Pol 71 2013 1091 1092
7. J. Wiebe, H. Mollmann, and A. Most Short-term outcome of patients with ST-segment elevation myocardial infarction (STEMI) treated with an everolimus-eluting bioresorbable vascular scaffold Clin Res Cardiol 103 2014 141 148
8. T. Kajiya, M. Liang, and R.K. Sharma Everolimus-eluting bioresorbable vascular scaffold (BVS) implantation in patients with ST-segment elevation myocardial infarction (STEMI) EuroIntervention 9 2013 501 504
9. T. Gori, E. Schulz, and U. Hink Early outcome after implantation of Absorb bioresorbable drug-eluting scaffolds in patients with acute coronary syndromes EuroIntervention 9 2014 1036 1041
10. P.W. Serruys, Y. Onuma, and D. Dudek Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes J Am Coll Cardiol 58 2011 1578 1588
11. T.F. Luscher, M. Pieper, and M. Tendera A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study Eur Heart J 30 2009 1590 1597
12. L. Raber, H. Kelbaek, and M. Ostojic Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial JAMA 308 2012 777 787
13. W.C. Kang, T. Ahn, and K. Lee Comparison of zotarolimus-eluting stents versus sirolimus-eluting stents versus paclitaxel-eluting stents for primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: results from the Korean Multicentre Endeavor (KOMER) acute myocardial infarction (AMI) trial EuroIntervention 7 2011 936 943
14. T. Palmerini, P. Genereux, and A. Caixeta Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial J Am Coll Cardiol 57 2011 2389 2397
15. D. Dvir, I.M. Barbash, and R. Torguson Clinical outcomes after treating acute coronary syndrome patients with a drug-eluting stent: results from REWARDS-EMI (Endeavor for Myocardial Infarction Registry) Cardiovasc Revasc Med 14 2013 128 133
16. M. Sabate, A. Cequier, and A. Iniguez Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial Lancet 380 2012 1482 1490
17. D. Capodanno, T. Gori, and H. Nef Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry EuroIntervention 10 2015 1144 1153
18. Y.J. Zhang, C.V. Bourantas, and T. Muramatsu Comparison of acute gain and late lumen loss after PCI with bioresorbable vascular scaffolds versus everolimus-eluting stents: an exploratory observational study prior to a randomised trial EuroIntervention 10 2014 672 680
19. L. Raber, T. Zanchin, and S. Baumgartner Differential healing response attributed to culprit lesions of patients with acute coronary syndromes and stable coronary artery after implantation of drug-eluting stents: an optical coherence tomography study Int J Cardiol 173 2014 259 267
20. R.J. van Geuns, C. Tamburino, and J. Fajadet Self-expanding versus balloon-expandable stents in acute myocardial infarction: results from the APPOSITION II study: self-expanding stents in ST-segment elevation myocardial infarction J Am Coll Cardiol Intv 5 2012 1209 1219
21. G. Guagliumi, M.A. Costa, and V. Sirbu Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial Circulation 123 2011 274 281
22. H.G. Bezerra, M.A. Costa, G. Guagliumi, A.M. Rollins, and D.I. Simon Intracoronary optical coherence tomography: a comprehensive review clinical and research applications J Am Coll Cardiol Intv 2 2009 1035 1046
23. G. Montalescot, U. Sechtem, and S. Achenbach 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the Management of Stable Coronary Artery Disease of the European Society of Cardiology Eur Heart J 34 2013 2949 3003
24. D. Dudek, Y. Onuma, J.A. Ormiston, L. Thuesen, K. Miquel-Hebert, and P.W. Serruys Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial EuroIntervention 7 2012 1060 1061